21 May 2009
Results of kidney’s transplantation procured from expanded criteria donors
P Domagała, A Kwiatkowski, M Wszoła, J Czerwiński, Ł Panufnik, K Ostrowski, L Pączek, M Durlik, A ChmuraAnn Transplant 2009; 14(1): 54-54 :: ID: 880396
Abstract
Background: Kidney transplantation is the treatment of choice for patients with end-stage renal disease. Organ shortage is the main barrier to offer this treatment to all who need it. Using expanded criteria donor's (ECD) organs is one of the strategies for making more transplants available. Aim: The aim of this study was to assess the results of kidney transplantation procured from expanded criteria donors.
Material/Methods: One hundred and seventy two patients received cadaveric renal transplants between January 1st, 2006 and August 31st, 2008. Data on donors and recipients was collected. Patient and graft survival, as well as immediate, delayed and slow graft function were analysed. Kidney recipients' function was assessed by serum creatinine concentration and creatinine clearance according to Cockroft-Gault formula at seven days, 1, 3, 6, 12 and 24 months post transplantation. The follow-up was completed on November 30[sup]th[/sup], 2008.
Results: Average 1-year graft survival was 86.9% for the whole group and mean creatinine concentration was 1.58 mg/dl. One case of primary nonfunction was observed (0.6%). More than 25% of transplanted kidneys were harvested from ECD. There were no significant differences in patient's survival between recipients of standard criteria donor (SCD) and ECD organs. Graft's survival was higher in the SCD group than in the ECD group (one-year survival - 94.4% vs. 62.5%, p=0.004). There were no differences in the incidence of primary non function and delayed graft function between the groups. Recipients of ECD kidneys were more likely to have slow graft function (69.2% vs. 37.8%, p=0.033).
Conclusions: There is no significant difference in patient's survival between
recipients of kidney harvested from expanded and standard criteria donors.
Expanded criteria donor's kidneys have lower graft survival rates. There is no
significant difference in the incidence of delayed graft function between recipients of kidney harvested from expanded and standard criteria donors.
Keywords: Kidney Transplantation
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588